CAD-031
Modify Date: 2024-02-29 05:47:57
CAD-031 structure
|
Common Name | CAD-031 | ||
|---|---|---|---|---|
| CAS Number | 2071209-49-7 | Molecular Weight | 404.312 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H14F6N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CAD-031CAD-031 (CAD31) is a novel brain penetrant, J147-derivative that has enhanced neurogenic activity over J147 in human neural precursor cells (NPCs); also stimulates the division of NPCs in the subventricular zone of old APPswe/PS1ΔE9 mice; rescues primary cortical neurons from oxytosis, and effectively reduce oxidative stress with EC50 of 20 nM; also prevents loss of energy metabolism that leads to neuron cell death in an in vitro ischemia model with EC50 of 47 nM; target fatty acid metabolism and inflammation, exhibits therapeutic efficacy on cognitive and physiological parameters in mouse model of AD . |
| Name | CAD-031 |
|---|
| Description | CAD-031 (CAD31) is a novel brain penetrant, J147-derivative that has enhanced neurogenic activity over J147 in human neural precursor cells (NPCs); also stimulates the division of NPCs in the subventricular zone of old APPswe/PS1ΔE9 mice; rescues primary cortical neurons from oxytosis, and effectively reduce oxidative stress with EC50 of 20 nM; also prevents loss of energy metabolism that leads to neuron cell death in an in vitro ischemia model with EC50 of 47 nM; target fatty acid metabolism and inflammation, exhibits therapeutic efficacy on cognitive and physiological parameters in mouse model of AD . |
|---|---|
| References | References 1. Daugherty D, et al. Alzheimers Res Ther. 2017 Jul 14;9(1):50. View Related Products by Target Other Targets |
| Molecular Formula | C18H14F6N2O2 |
|---|---|
| Molecular Weight | 404.312 |